000 | 01942 a2200529 4500 | ||
---|---|---|---|
005 | 20250516044803.0 | ||
264 | 0 | _c20120123 | |
008 | 201201s 0 0 eng d | ||
022 | _a1096-9071 | ||
024 | 7 |
_a10.1002/jmv.22136 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOhta, Motoki | |
245 | 0 | 0 |
_aEpstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma. _h[electronic resource] |
260 |
_bJournal of medical virology _cSep 2011 |
||
300 |
_a1582-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAcyclovir _xadministration & dosage |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aBrain Neoplasms _xtherapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
650 | 0 | 4 |
_aEncephalitis, Varicella Zoster _xdrug therapy |
650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
650 | 0 | 4 | _aHerpesvirus 4, Human |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 | _aLymphopenia |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xdiagnosis |
650 | 0 | 4 |
_aMedulloblastoma _xtherapy |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aVirus Activation |
700 | 1 | _aTaga, Takashi | |
700 | 1 | _aNomura, Akitaka | |
700 | 1 | _aKato, Hirofumi | |
700 | 1 | _aTakano, Tomoyuki | |
700 | 1 | _aMaruo, Yoshihiro | |
700 | 1 | _aTakeuchi, Yoshihiro | |
700 | 1 | _aIshida, Mitsuaki | |
700 | 1 | _aOhta, Shigeru | |
773 | 0 |
_tJournal of medical virology _gvol. 83 _gno. 9 _gp. 1582-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.22136 _zAvailable from publisher's website |
999 |
_c20991618 _d20991618 |